Patents by Inventor Makoto A. Inoue

Makoto A. Inoue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10837990
    Abstract: A semiconductor device is provided which can detect a fluctuation of a power supply voltage. The semiconductor device includes a counter circuit that outputs a signal when a period during which a power supply voltage of a system to be monitored is lower than or equal to a first voltage value exceeds a predetermined time, a first flag circuit that sets a first flag based on the signal, a second flag circuit that sets a second flag when the power supply voltage becomes a second voltage value or lower, and a circuit that outputs a reset signal that resets the system when both the first and the second flags are set. The first voltage value and the second voltage value are higher than a minimum voltage that guarantees normal operation of the system. The first voltage value is higher than the second voltage value.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: November 17, 2020
    Assignee: RENESAS ELECTRONICS CORPORATION
    Inventors: Toshiharu Saito, Makoto Inoue, Yasunori Kubota
  • Publication number: 20200353070
    Abstract: The present invention provides polypeptides for selectively inducing target antigen-specific CD8-positive T-cell responses. Since induction of human immunodeficiency virus (HIV)-specific CD4-positive T-cell responses by vaccine could promote HIV infection, an HIV vaccine antigen that selectively induces HIV-specific CD8-positive T-cell responses would be useful if obtained. Thus, in the present invention, polypeptide antigens were designed in which 8- to 12-residue amino acid sequences divided from the amino acid sequence of a target antigen protein were connected in an order different from that of the original amino acid sequence. DNA and viral vector vaccines expressing these antigens were tested by inoculation into monkeys. As a result, they were shown to be able to efficiently induce antigen-specific CD8-positive T-cell responses in a selective manner. The instant antigens may be useful as vaccine antigens that induce CD8-positive T cells in a highly selective manner.
    Type: Application
    Filed: January 21, 2019
    Publication date: November 12, 2020
    Inventors: Tetsuro MATANO, Hiroshi ISHII, Makoto INOUE, Takashi HIRONAKA, Tsugumine SHU, Toyotaka MORI
  • Patent number: 10792357
    Abstract: The present invention relates to a vector(s) containing and expressing an optimized HIV EnvF gene, methods for making the same and cell substrates qualified for vaccine production which may comprise vector(s) containing optimized HIV genes.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: October 6, 2020
    Assignee: INTERNATIONAL AIDS VACCINE INITIATIVE
    Inventors: Christopher L. Parks, Maoli Yuan, Xinsheng Zhang, Aaron Wilson, Angela Grazia Lombardo, Eddy Sayeed, Josephine Helena Cox, Takashi Hironaka, Makoto Inoue, Hiroto Hara
  • Publication number: 20200283797
    Abstract: An objective of the present invention is to provide an improved negative-strand RNA viral vector and a use thereof, the negative-strand RNA viral vector exhibiting transient high expression of genes loaded in the vector and enabling the rapid removal of the vector after said expression. It was discovered that by adding a micro-RNA target sequence to the NP, P, or L gene of a negative-strand RNA viral vector, it is possible to control the expression of the vector depending on the micro-RNA expressed by the introduction cell. In particular, when a micro-RNA target sequence was added to the NP or P gene, the expression of the vector decreased depending on the micro-RNA, and the removal of the vector was promoted, while the effect was reversed when a micro-RNA target sequence was added to the L gene. The vector can be applied in cell therapy and regenerative medicine and can be used as a therapeutic vector that targets cancer.
    Type: Application
    Filed: November 4, 2016
    Publication date: September 10, 2020
    Applicant: ID Pharma Co., Ltd.
    Inventors: Koichi SAEKI, Kohji KUSANO, Hiroto HARA, Makoto INOUE, Jitsutaro KAWAGUCHI
  • Patent number: 10744852
    Abstract: A vehicular air-conditioning device includes a blowing port mode door as an air volume regulator that regulates volumes of air-conditioning air blown to a driver seat area, a front passenger seat area, and a rear seat area inside a vehicle compartment, and an air-conditioning controller activated by an activation signal outputted from a body controller in response to opening and closing of a rear seat door during a stoppage of a vehicle system. The air-conditioning controller is capable of operating an actuator for driving the blowing port mode door to blow the air-conditioning air to the rear seat area when an activation switch of the vehicle system is turned on in a state where the air-conditioning control unit has been activated by the activation signal.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: August 18, 2020
    Assignees: DENSO CORPORATION, TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Takeshi Wakisaka, Kazuya Nishiuma, Toshinao Aoki, Yoshinori Ichishi, Takayuki Shimauchi, Makoto Inoue, Daisuke Setoguchi, Yoshinori Okuno, Tatsuru Tanaka, Kazuaki Shingo
  • Publication number: 20200252044
    Abstract: A high-frequency device includes: a circuit substrate including dielectric layers that are stacked, wiring patterns located on at least one of the dielectric layers, and a passive element formed of at least one of the wiring patterns, the circuit substrate having a first surface that is a surface of an outermost dielectric layer in a stacking direction of the dielectric layers; a terminal for connecting the high-frequency device to an external circuit, the terminal being located on the first surface and electrically connected to the passive element through a first path in the circuit substrate; and an acoustic wave element located on the first surface and electrically connected to the passive element through a second path in the circuit substrate.
    Type: Application
    Filed: December 19, 2019
    Publication date: August 6, 2020
    Applicant: TAIYO YUDEN CO., LTD.
    Inventors: Hideyuki SEKINE, Hosung CHOO, Makoto INOUE
  • Publication number: 20200235714
    Abstract: A filter includes: a substrate; input and output terminals located on the substrate; a resonant circuit located in a series pathway between the input and output terminals; a first component including a first inductor, which is electrically connected between a first node in the series pathway and a ground, and mounted in a first region on the substrate; a second component including a second inductor, which is electrically connected between a second node different from the first node in the series pathway and a ground, and mounted in a second region different from the first region on the substrate; and a third component including an acoustic wave resonator, which is electrically connected between a third node between the first and second nodes in the series pathway and a ground, and mounted in a third region between the first and second regions on the substrate.
    Type: Application
    Filed: December 18, 2019
    Publication date: July 23, 2020
    Applicant: TAIYO YUDEN CO., LTD.
    Inventors: Jaeho JEONG, Shuei HASHIMOTO, Naoyuki TASAKA, Sachiko TANAKA, Makoto INOUE
  • Publication number: 20200216858
    Abstract: The present invention provides novel donor polynucleotides formed by linking the two ends of a genomic fragment containing a cleavable site by a polynucleotide carrying a positive selection marker gene and a negative selection marker gene. Use of the donor polynucleotide makes it possible to modify only a target gene with avoiding the possibility of introducing mutations to sequences, called “off-target”, which are other than the target sequence, by introducing cleavage in a homologous site of the donor polynucleotide without introducing cleavage in a target gene locus.
    Type: Application
    Filed: July 19, 2018
    Publication date: July 9, 2020
    Applicant: I'ROM GROUP CO., LTD.
    Inventors: Kohji KUSANO, Takayuki KITOGO, Makoto INOUE, Tsugumine SHU, Toyotaka MORI
  • Patent number: 10704061
    Abstract: This invention relates to lentiviral gene transfer vectors pseudotyped with hemagglutinin-neuraminidase (HN) and fusion (F) proteins from a respiratory paramyxovirus, comprising a promoter and a transgene; and methods of making the same. The present invention also relates to the use of said vectors in gene therapy, particularly for the treatment of respiratory tract diseases such as Cystic Fibrosis (CF).
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: July 7, 2020
    Assignees: IP2IPO INNOVATIONS LIMITED, ID PHARMA CO., LTD.
    Inventors: Eric Walter Frederick Wolfgang Alton, Uta Griesenbach, Kamila Malgorzata Pytel, Michael Christian Paul-Smith, Ian Andrew Pringle, Stephen Charles Hyde, Deborah Rebecca Gill, Lee Adrian Davies, Alan Christopher Boyd, Gerard McLachlan, Makoto Inoue
  • Patent number: 10700666
    Abstract: A filter circuit includes: a first element that is a first capacitor or a first inductor connected in series between input and output terminals; a second element that is connected in parallel to the first element between the input and output terminals, is a second inductor when the first element is the first capacitor, and is a second capacitor when the first element is the first inductor; a third element that is connected in parallel to the first element and in series with the second element between the input and output terminals, is a third inductor when the first element is the first capacitor, and is a third capacitor when the first element is the first inductor; and an acoustic wave resonator having a first end coupled to a first node between the second element and the third element and a second end coupled to a ground terminal.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: June 30, 2020
    Assignee: TAIYO YUDEN CO., LTD.
    Inventors: Sachiko Tanaka, Makoto Inoue, Naoyuki Tasaka
  • Publication number: 20200155669
    Abstract: In this invention, a non-infectious particle has been produced, comprising a pathogen antigen protein caused to be expressed on the surface of a virus particle having at least one species of paramyxovirus envelope protein missing from the particle. This particle has been found to hold within the particle a large amount of antigen protein compared to an infectious particle, and to be capable of eliciting a host immune response with extremely high efficiency. The non-infectious particle according to the present invention is useful as a vaccine against a pathogenic virus, or the like.
    Type: Application
    Filed: November 17, 2017
    Publication date: May 21, 2020
    Inventors: Tetsuro MATANO, Makoto INOUE, Hiroto HARA, Tsugumine SHU
  • Publication number: 20200162415
    Abstract: A communication method includes the steps of transmitting, by means of a first communication apparatus, personal information to a second communication apparatus; receiving, by means of the second communication apparatus, the personal information and searching, by means of the second communication apparatus, whether or not personal information having the same content as the received personal information exists in the second communication apparatus; and notifying, by means of the second communication apparatus, the first communication apparatus of a search result.
    Type: Application
    Filed: January 23, 2020
    Publication date: May 21, 2020
    Applicant: Sony Cororation
    Inventors: Yoichiro Sako, Mitsuru Takehara, Toshiro Terauchi, Makoto Inoue, Motoyuki Takai, Masamichi Asukai, Katsuya Shirai, Takatoshi Nakamura, Toru Sasaki, Yuichi Sakai, Masafumi Matsuda
  • Patent number: 10587567
    Abstract: A communication method includes the steps of transmitting, by means of a first communication apparatus, personal information to a second communication apparatus; receiving, by means of the second communication apparatus, the personal information and searching, by means of the second communication apparatus, whether or not personal information having the same content as the received personal information exists in the second communication apparatus; and notifying, by means of the second communication apparatus, the first communication apparatus of a search result.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: March 10, 2020
    Assignee: Sony Corporation
    Inventors: Yoichiro Sako, Mitsuru Takehara, Toshiro Terauchi, Makoto Inoue, Motoyuki Takai, Masamichi Asukai, Katsuya Shirai, Takatoshi Nakamura, Toru Sasaki, Yuichi Sakai, Masafumi Matsuda
  • Patent number: 10581121
    Abstract: Provided is a balance correction control apparatus to control a balance correction apparatus designed to correct a balance between voltages of a first electric storage cell and a second electric storage cell connected in series based on a target setting for an SOC of each of the first electric storage cell and the second electric storage cell. The balance correction control apparatus includes a cell characteristic obtaining unit operable to obtain at least one cell characteristic selected from the group consisting of a degree of deterioration, a cell capacity and a temperature of each of the first electric storage cell and the second electric storage cell, and a target setting determining unit operable to determine the target setting for the SOC of each of the first electric storage cell and the second electric storage cell based on the at least one cell characteristic obtained by the cell characteristic obtaining unit.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: March 3, 2020
    Assignee: NExT-e Solutions Inc.
    Inventors: Fumiaki Nakao, Makoto Inoue
  • Patent number: 10518161
    Abstract: A sound-output-control device including an acquisition unit which acquires an anaerobic threshold, a reception unit which receives an input about exercise intensity, a calculation unit which calculates a value indicating a target heart rate of a user on the basis of the acquired anaerobic threshold and the received exercise-intensity input, a detection unit which detects a value indicating the current tempo of a physical exercise done by the user, and a control unit that controls a sound output on the basis of a result of a comparison of the target heart-rate value calculated by the calculation unit and the current physical-exercise-tempo value detected by the detection unit, so as to lead a heart rate of the user so that the heart rate of the user attains the target heart rate is provided.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: December 31, 2019
    Assignee: Sony Corporation
    Inventors: Masamichi Asukai, Katsuya Shirai, Makoto Inoue, Akane Sano
  • Publication number: 20190238496
    Abstract: A communication method includes the steps of transmitting, by means of a first communication apparatus, personal information to a second communication apparatus; receiving, by means of the second communication apparatus, the personal information and searching, by means of the second communication apparatus, whether or not personal information having the same content as the received personal information exists in the second communication apparatus; and notifying, by means of the second communication apparatus, the first communication apparatus of a search result.
    Type: Application
    Filed: April 9, 2019
    Publication date: August 1, 2019
    Applicant: Sony Corporation
    Inventors: Yoichiro Sako, Mitsuru Takehara, Toshiro Terauchi, Makoto Inoue, Motoyuki Takai, Masamichi Asukai, Katsuya Shirai, Takatoshi Nakamura, Toru Sasaki, Yuichi Sakai, Masafumi Matsuda
  • Publication number: 20190225986
    Abstract: The present inventors successfully introduced genes into stem cells of airway epithelial tissues using simian immunodeficiency virus vectors pseudotyped with F and HN, which are envelope glycoproteins of Sendai virus. Gene transfer into airway epithelial tissue stem cells using a vector of the present invention is useful for gene therapy of genetic respiratory diseases such as cystic fibrosis. Furthermore, it is possible to select respiratory organs such as the lungs as production tissues for providing proteins that are deficient due to genetic diseases.
    Type: Application
    Filed: November 30, 2018
    Publication date: July 25, 2019
    Inventors: Katsuyuki Mitomo, Makoto Inoue, Hitoshi Iwasaki, Mamoru Hasegawa, Eric W. Alton, Uta Griesenbach
  • Publication number: 20190201522
    Abstract: The present invention relates to a vector(s) containing and expressing an optimized HIV EnvF gene, methods for making the same and cell substrates qualified for vaccine production which may comprise vector(s) containing optimized HIV genes.
    Type: Application
    Filed: March 4, 2019
    Publication date: July 4, 2019
    Inventors: Christopher L. Parks, Maoli Yuan, Xinsheng Zhang, Aaron Wilson, Angela Grazia Lombardo, Eddy Sayeed, Josephine Helena Cox, Takashi Hironaka, Makoto Inoue, Hiroto Hara
  • Publication number: 20190178920
    Abstract: A semiconductor device is provided which can detect a fluctuation of a power supply voltage. The semiconductor device includes a counter circuit that outputs a signal when a period during which a power supply voltage of a system to be monitored is lower than or equal to a first voltage value exceeds a predetermined time, a first flag circuit that sets a first flag based on the signal, a second flag circuit that sets a second flag when the power supply voltage becomes a second voltage value or lower, and a circuit that outputs a reset signal that resets the system when both the first and the second flags are set. The first voltage value and the second voltage value are higher than a minimum voltage that guarantees normal operation of the system. The first voltage value is higher than the second voltage value.
    Type: Application
    Filed: October 29, 2018
    Publication date: June 13, 2019
    Inventors: Toshiharu SAITO, Makoto INOUE, Yasunori KUBOTA
  • Patent number: RE47948
    Abstract: By allowing the movement of a user to affect the playback of content, the entertainment characteristic or uplifting spirits derived from content playback itself can be enhanced. The timing at which the user places his/her foot on the ground while walking or the timing at which the user shakes or changes from swinging in one direction to swinging to another direction is detected. Then, content, such as a music piece or moving pictures, is played back by allowing the timing of beats or bars of the music piece or the timing of scene changes or cut changes of the moving pictures to be synchronized with the timing of the movement of the user.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: April 14, 2020
    Assignee: Sony Corporation
    Inventors: Motoyuki Takai, Toshiro Terauchi, Yoichiro Sako, Yasushi Miyajima, Kosei Yamashita, Makoto Inoue, Masamichi Asukai, Katsuya Shirai, Kenichi Makino